Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
30.25
-0.02 (-0.07%)
BSENSE

Jun 18

BSE+NSE Vol: 16.04 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.25",
    "chg": -0.02,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "30.27",
    "mcapval": "47.88 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "16.04 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4000798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MangalamDrugsan_mojoScore_4000798.png",
        "date": "2026-05-20 10:10:21",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "When is the next results date for Mangalam Drugs and Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mangalam-drugs-and-organics-ltd-3980424",
        "imagepath": "",
        "date": "2026-05-07 23:16:40",
        "description": "The next results date for Mangalam Drugs and Organics Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3964269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3964269.png",
        "date": "2026-04-27 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3944648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3944648.png",
        "date": "2026-04-13 10:10:14",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 13 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3937245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_stocks_hitting_upper_circuit_3937245.png",
        "date": "2026-04-08 10:00:08",
        "description": "At Rs 31.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 4.99% on 8 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs Gains 2.29%: Circuit Limits Highlight Volatility and Investor Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-gains-229-circuit-limits-highlight-volatility-and-investor-sentiment-3933465",
        "imagepath": "",
        "date": "2026-04-05 16:00:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Lower circuit hit amid heavy selling pressure (₹27.05)</p>\n                    <p><strong>1 Apr:</strong> Upper circuit hit on strong buying interest (₹28.05)</p>\n                    <p><strong>2 Apr:</strong> Marginal gain with subdued volume (₹29.06)</p>\n                    <p><strong>3 Apr:</strong> Week closes at ₹29.06, up 2.29% vs Sensex down 0.29%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.74</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.29.06</div..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3930208",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3930208.png",
        "date": "2026-04-02 10:10:16",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3928514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_stocks_hitting_upper_circuit_3928514.png",
        "date": "2026-04-01 10:00:09",
        "description": "At Rs 28.50, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs Falls 4.60%: Circuit Hits and Volatility Define the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-falls-460-circuit-hits-and-volatility-define-the-week-3922325",
        "imagepath": "",
        "date": "2026-03-28 17:05:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock declines 1.41% amid broad market sell-off</p>\n                    <p><strong>24 Mar:</strong> Hits upper circuit at Rs.30.29, surging 4.16%</p>\n                    <p><strong>25 Mar:</strong> Recovers modestly, closing flat at Rs.29.36 (+1.14%)</p>\n                    <p><strong>27 Mar:</strong> Plunges to lower circuit, closing at Rs.28.41 (-3.24%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.78</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.28.41</di..."
      }
    ],
    "total": 15,
    "sid": "138636",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Annual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Submission of Annual Secretarial Compliance Report for the period ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-May-2026",
      "details": "Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

25-May-2026 | Source : BSE

Annual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.

Compliances-Reg.24(A)-Annual Secretarial Compliance

25-May-2026 | Source : BSE

Submission of Annual Secretarial Compliance Report for the period ended 31st March 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

19-May-2026 | Source : BSE

Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available